499 related articles for article (PubMed ID: 24319217)
1. Transfusion therapy for sickle cell disease: a balancing act.
Chou ST
Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217
[TBL] [Abstract][Full Text] [Related]
2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
3. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
5. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
6. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
7. Consequences and management of iron overload in sickle cell disease.
Porter J; Garbowski M
Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
[TBL] [Abstract][Full Text] [Related]
8. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
[TBL] [Abstract][Full Text] [Related]
9. Management of Patients with Sickle Cell Disease Using Transfusion Therapy: Guidelines and Complications.
Chou ST; Fasano RM
Hematol Oncol Clin North Am; 2016 Jun; 30(3):591-608. PubMed ID: 27112998
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
[TBL] [Abstract][Full Text] [Related]
11. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
Leal I; Dos Santos TD; Gilli S; Castilho L
Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
13. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
15. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.
Chou ST; Alsawas M; Fasano RM; Field JJ; Hendrickson JE; Howard J; Kameka M; Kwiatkowski JL; Pirenne F; Shi PA; Stowell SR; Thein SL; Westhoff CM; Wong TE; Akl EA
Blood Adv; 2020 Jan; 4(2):327-355. PubMed ID: 31985807
[TBL] [Abstract][Full Text] [Related]
16. Transfusion Therapy in Children With Sickle Cell Disease.
Inati A; Mansour AG; Sabbouh T; Amhez G; Hachem A; Abbas HA
J Pediatr Hematol Oncol; 2017 Mar; 39(2):126-132. PubMed ID: 27509379
[TBL] [Abstract][Full Text] [Related]
17. Current issues in blood transfusion for sickle cell disease.
Wahl S; Quirolo KC
Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
[TBL] [Abstract][Full Text] [Related]
18. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.
Wilkinson K; Harris S; Gaur P; Haile A; Armour R; Teramura G; Delaney M
Transfusion; 2012 Feb; 52(2):381-8. PubMed ID: 21827505
[TBL] [Abstract][Full Text] [Related]
19. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease.
Harm SK; Yazer MH; Monis GF; Triulzi DJ; Aubuchon JP; Delaney M
Am J Clin Pathol; 2014 Feb; 141(2):256-61. PubMed ID: 24436274
[TBL] [Abstract][Full Text] [Related]
20. Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion.
Roberts DO; Covert B; Lindsey T; Edwards V; McLaughlin L; Theus J; Wray RJ; Jupka K; Baker D; Robbins M; DeBaun MR
Immunohematology; 2012; 28(1):7-12. PubMed ID: 22646143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
